跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/NCT04555187
NCT04555187已完成不适用

Cardiovascular Risk Stratification in Covid-19

Oregon Health and Science University1 个研究点 分布在 1 个国家目标入组 1,355 人开始时间: 2020年6月8日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,355
试验地点
1
主要终点
Number and rate of persons with cardiovascular composite outcome
研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

This retrospective double-cohort study seeks to:

  1. Describe the cardiovascular manifestations and electrophysiological (EP) substrate in COVID-19 infection and their association with clinical outcomes; and
  2. Develop a method of cardiovascular risk stratification in COVID-19

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 89 Years（Adult, Older Adult）
性别
All
接受健康志愿者
否

入选标准

  • •age >=18y
  • •available data on Covid19 test in the electronic medical record (either positive or negative)

排除标准

  • •no data of Covid19 test

结局指标

主要结局

Number and rate of persons with cardiovascular composite outcome

时间窗: 6 months after Covid19 test

Number and rate of persons with composite of all-cause death, critical care utilization (ICU bed), development of a life-threatening arrhythmia (ventricular tachycardia/ventricular fibrillation or sudden cardiac arrest), acute heart failure, myocardial infarction (STEMI, NSTEMI, or silent MI), or incident stroke, whichever comes first.

次要结局

  • Rate of all-cause death outcome(6 months after covid19 test)
  • Rate of cardiac arrhythmia(6 months after covid19 test)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Larisa Tereshchenko

Associate Professor of Medicine

Oregon Health and Science University

研究点 (1)

Loading locations...

相似试验

招募中
不适用
Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)Heart Failure
NCT04983823Baker Heart and Diabetes Institute820
招募中
不适用
CardioVascular Disease Progression and Prognosis in COVID-19Covid19
NCT04606732University of Bologna2,000
Unknown
不适用
EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19Acute Myocardial Infarction
NCT04498091Centre Hospitalier Universitaire Dijon35
Unknown
不适用
Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19Covid19Myocardial InjuryCardiovascular DiseasesCardiovascular MorbidityHeart Failure
NCT04624503Humanitas Hospital, Italy500
Unknown
不适用
Myocardial Damage in COVID-19COVID-19Cardiovascular Diseases
NCT04312464Wuhan Union Hospital, China500
Cardiovascular Risk Stratification in Covid-19 | 临床试验